VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3252
-0.0088 (-2.63%)
At close: Aug 25, 2025, 4:00 PM
0.3275
+0.0023 (0.71%)
After-hours: Aug 25, 2025, 4:27 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $8.29 million as of August 25, 2025. Its market cap has decreased by -66.44% in one year.
Market Cap
8.29M
Enterprise Value
-31.24M
1-Year Change
-66.44%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $8.29M, a decrease of -96.39%. That is a compound annual growth rate of -45.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 8.51M | -82.78% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |